FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Jenni Vuola

Research Profile

Living Beings

Chemicals & Drugs

Disorders

Procedures

Physiology

Lymphocyte Activation

Anatomy

T-Lymphocytes

Co-author Network

Publications

TOP 3
Timothy Lahey; Todd Mackenzie; M I N Matee; Brian K Mitchell; Lillian Mtei; Kisali Pallangyo; Siddharth Sheth; Robert D Arbeit; Muhammad Bakari; C Robert Horsburgh; Jenni M Vuola; C Fordham von Reyn
Polyantigenic interferon-γ responses are associated with protection from TB among HIV-infected adults with childhood BCG immunization.
Timothy Lahey; Robert D Arbeit; Muhammad Bakari; C Robert Horsburgh; Mecky Matee; Richard Waddell; Lillian Mtei; Jenni M Vuola; Kisali Pallangyo; C Fordham von Reyn
Immunogenicity of a protective whole cell mycobacterial vaccine in HIV-infected adults: a phase III study in Tanzania.
Timothy Lahey; Siddharth Sheth; M I N Matee; Robert D Arbeit; C Robert Horsburgh; Lillian Mtei; Todd Mackenzie; Muhammad Bakari; Jenni M Vuola; Kisali Pallangyo; C Fordham von Reyn
Interferon γ responses to mycobacterial antigens protect against subsequent HIV-associated tuberculosis.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Jenni Vuola (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: Timothy Lahey; Todd Mackenzie; M I N Matee; Brian K Mitchell; Lillian Mtei; Kisali Pallangyo; Siddharth Sheth; Robert D Arbeit; Muhammad Bakari; C Robert Horsburgh; Jenni M Vuola; C Fordham von Reyn
Polyantigenic interferon-γ responses are associated with protection from TB among HIV-infected adults with childhood BCG immunization.
PloS one 2011;6(7):e22074.
2010: Timothy Lahey; Robert D Arbeit; Muhammad Bakari; C Robert Horsburgh; Mecky Matee; Richard Waddell; Lillian Mtei; Jenni M Vuola; Kisali Pallangyo; C Fordham von Reyn
Immunogenicity of a protective whole cell mycobacterial vaccine in HIV-infected adults: a phase III study in Tanzania.
Vaccine 2010;28(48):7652-8.
2010: Timothy Lahey; Siddharth Sheth; M I N Matee; Robert D Arbeit; C Robert Horsburgh; Lillian Mtei; Todd Mackenzie; Muhammad Bakari; Jenni M Vuola; Kisali Pallangyo; C Fordham von Reyn
Interferon γ responses to mycobacterial antigens protect against subsequent HIV-associated tuberculosis.
The Journal of infectious diseases 2010;202(8):1265-72.
2009: T A Partanen; P Vikatmaa; Erkki Tukiainen; Mauri Lepäntalo; Jenni M Vuola
Outcome after injections of crushed tablets in intravenous drug abusers in the Helsinki University Central Hospital.
European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery 2009;37(6):704-11.
2009: Minna K Kyläniemi; Anu Haveri; Jenni M Vuola; Mirja Puolakkainen; Riitta Lahesmaa
Gene expression signatures characterizing the development of lymphocyte response during experimental Chlamydia pneumoniae infection.
Microbial pathogenesis 2009;46(5):235-42.
2008: Tuula Penttilä; Anu Haveri; Anne Tammiruusu; Jenni M Vuola; Riitta Lahesmaa; Mirja Puolakkainen
Chlamydia pneumoniae infection in IL-10 knock out mice: accelerated clearance but severe pulmonary inflammatory response.
Microbial pathogenesis 2008;45(1):25-9.
2007: Laura Mannonen; Tuomas Nikula; Anu Haveri; Arja Reinikainen; Jenni M Vuola; Riitta Lahesmaa; Mirja Puolakkainen
Up-regulation of host cell genes during interferon-gamma-induced persistent Chlamydia pneumoniae infection in HL cells.
The Journal of infectious diseases 2007;195(2):212-9.
2007: Anne Tammiruusu; Tuula Penttilä; Riitta Lahesmaa; Matti Sarvas; Mirja Puolakkainen; Jenni M Vuola
Intranasal administration of chlamydial outer protein N (CopN) induces protection against pulmonary Chlamydia pneumoniae infection in a mouse model.
Vaccine 2007;25(2):283-90.
2007: M I N Matee; Timothy Lahey; Jenni M Vuola; Lillian Mtei; Bernard F Cole; Muhammad Bakari; Robert D Arbeit; C Robert Horsburgh; Kisali Pallangyo; C Fordham von Reyn
Baseline mycobacterial immune responses in HIV-infected adults primed with bacille Calmette-Guérin during childhood and entering a tuberculosis booster vaccine trial.
The Journal of infectious diseases 2007;195(1):118-23.
2006: Tuula Penttilä; Eva Wahlström; Jenni M Vuola; Matti Sarvas; Mirja Puolakkainen
Systemic and mucosal antibody response in experimental Chlamydia pneumoniae infection of mice.
Comparative medicine 2006;56(4):272-8.
2006: Sarah Gilbert; Vasee S Moorthy; Laura Andrews; Ansar A Pathan; Samuel J McConkey; Jenni M Vuola; Sheila Keating; Tamara Berthoud; Daniel Webster; Helen McShane; Adrian V S Hill
Synergistic DNA-MVA prime-boost vaccination regimes for malaria and tuberculosis.
Vaccine 2006;24(21):4554-61.
2006: Susanna Dunachie; Michael Walther; Jenni M Vuola; Daniel P Webster; Sheila Keating; Tamara Berthoud; Laura Andrews; Philip Bejon; Ian Poulton; Geoffrey Butcher; Kate Watkins; Robert E Sinden; Amanda Leach; Philippe Moris; Nadia Tornieporth; Joerg Schneider; Filip Dubovsky; Eveline Tierney; Jack Williams; Donald Heppner; Sarah Gilbert; Joe Cohen; Adrian V S Hill
A clinical trial of prime-boost immunisation with the candidate malaria vaccines RTS,S/AS02A and MVA-CS.
Vaccine 2006;24(15):2850-9.
2005: Sheila Keating; Philip Bejon; Tamara Berthoud; Jenni M Vuola; Stephen Todryk; Daniel P Webster; Susanna Dunachie; Vasee S Moorthy; Samuel J McConkey; Sarah Gilbert; Adrian V S Hill
Durable human memory T cells quantifiable by cultured enzyme-linked immunospot assays are induced by heterologous prime boost immunization and correlate with protection against malaria.
Journal of immunology (Baltimore, Md. : 1950) 2005;175(9):5675-80.
2005: Anne Tammiruusu; A Haveri; Steve Pascolo; Riitta Lahesmaa; Stefan Stevanovic; Hans-Georg Rammensee; Matti Sarvas; Mirja Puolakkainen; Jenni M Vuola
Clearance of Chlamydia pneumoniae infection in H-2 class I human leucocyte antigen-A2.1 monochain transgenic mice.
Scandinavian journal of immunology 2005;62(2):131-9.
2005: Lillian Mtei; M I N Matee; Oliver Herfort; Muhammad Bakari; C Robert Horsburgh; Richard Waddell; Bernard F Cole; Jenni M Vuola; Susan Tvaroha; Barry Kreiswirth; Kisali Pallangyo; C Fordham von Reyn
High rates of clinical and subclinical tuberculosis among HIV-infected ambulatory subjects in Tanzania.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2005;40(10):1500-7.
2005: Daniel P Webster; Susanna Dunachie; Jenni M Vuola; Tamara Berthoud; Sheila Keating; Stephen M Laidlaw; Samuel J McConkey; Ian Poulton; Laura Andrews; Rikke F Andersen; Philip Bejon; Geoffrey Butcher; Robert Sinden; Michael A Skinner; Sarah Gilbert; Adrian V S Hill
Enhanced T cell-mediated protection against malaria in human challenges by using the recombinant poxviruses FP9 and modified vaccinia virus Ankara.
Proceedings of the National Academy of Sciences of the United States of America 2005;102(13):4836-41.
2005: Michael Walther; Susanna Dunachie; Sheila Keating; Jenni M Vuola; Tamara Berthoud; Annette Schmidt; Carolin Maier; Laura Andrews; Rikke F Andersen; Sarah Gilbert; Ian Poulton; Daniel Webster; Filip Dubovsky; Eveline Tierney; Pramod Sarpotdar; Simon Correa; Angela Huntcooke; Geoffrey Butcher; Jack Williams; Robert E Sinden; george thornton; Adrian V S Hill
Safety, immunogenicity and efficacy of a pre-erythrocytic malaria candidate vaccine, ICC-1132 formulated in Seppic ISA 720.
Vaccine 2005;23(7):857-64.
2005: Jenni M Vuola; Sheila Keating; Daniel P Webster; Tamara Berthoud; Susanna Dunachie; Sarah Gilbert; Adrian V S Hill
Differential immunogenicity of various heterologous prime-boost vaccine regimens using DNA and viral vectors in healthy volunteers.
Journal of immunology (Baltimore, Md. : 1950) 2005;174(1):449-55.
2004: Matti Ristola; Jenni M Vuola; Martti Valle; C Fordham von Reyn
Antibody responses to intradermal recombinant hepatitis B immunization among HIV-positive subjects.
Vaccine 2004;23(2):205-9.
2004: Tuula Penttilä; Anne Tammiruusu; Peter Liljeström; Matti Sarvas; P Helena Mäkelä; Jenni M Vuola; Mirja Puolakkainen
DNA immunization followed by a viral vector booster in a Chlamydia pneumoniae mouse model.
Vaccine 2004;22(25-26):3386-94.
2003: Jenni M Vuola; Matti Ristola; Bernard Cole; Annika Järviluoma; Susan Tvaroha; Terhi Rönkkö; Outi Rautio; Robert D Arbeit; C Fordham von Reyn
Immunogenicity of an inactivated mycobacterial vaccine for the prevention of HIV-associated tuberculosis: a randomized, controlled trial.
AIDS (London, England) 2003;17(16):2351-5.
2003: Samuel J McConkey; William H H Reece; Vasee S Moorthy; Daniel Webster; Susanna Dunachie; Geoffrey Butcher; Jenni M Vuola; Tom J Blanchard; Philip K Gothard; Kate Watkins; Carolyn M Hannan; Simone Everaere; Karen Brown; Kent Kester; James Cummings; Jackie Williams; Donald Heppner; Ansar A Pathan; Katie L Flanagan; Nirmalan Arulanantham; Mark T M Roberts; Michael Roy; Geoffrey L Smith; Joerg Schneider; T E A Peto; Robert E Sinden; Sarah Gilbert; Adrian V S Hill
Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans.
Nature medicine 2003;9(6):729-35.
2003: Ulla Airaksinen; Tuula Penttilä; Eva Wahlström; Jenni M Vuola; Mirja Puolakkainen; Matti Sarvas
Production of Chlamydia pneumoniae proteins in Bacillus subtilis and their use in characterizing immune responses in the experimental infection model.
Clinical and diagnostic laboratory immunology 2003;10(3):367-75.
2002: C Fordham von Reyn; Jenni M Vuola
New vaccines for the prevention of tuberculosis.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2002;35(4):465-74.
2002: Anne Sarén; Steve Pascolo; Stefan Stevanovic; Tilman Dumrese; Mirja Puolakkainen; Matti Sarvas; Hans-Georg Rammensee; Jenni M Vuola
Identification of Chlamydia pneumoniae-derived mouse CD8 epitopes.
Infection and immunity 2002;70(7):3336-43.
2000: Tuula Penttilä; Jenni M Vuola; V Puurula; M Anttila; Matti Sarvas; Nina Rautonen; P Helena Mäkelä; Mirja Puolakkainen
Immunity to Chlamydia pneumoniae induced by vaccination with DNA vectors expressing a cytoplasmic protein (Hsp60) or outer membrane proteins (MOMP and Omp2).
Vaccine 2000;19(9-10):1256-65.
2000: Jenni M Vuola; V Puurula; M Anttila; P Helena Mäkelä; Nina Rautonen
Acquired immunity to Chlamydia pneumoniae is dependent on gamma interferon in two mouse strains that initially differ in this respect after primary challenge.
Infection and immunity 2000;68(2):960-4.